As the Director and Team Lead of Rebate Administration at Pfizer, Doug Behm plays a pivotal role in navigating the complexities of market access within the pharmaceutical landscape. With over fifteen years of experience, Doug has cultivated a deep expertise in contract operations and managed...
As the Director and Team Lead of Rebate Administration at Pfizer, Doug Behm plays a pivotal role in navigating the complexities of market access within the pharmaceutical landscape. With over fifteen years of experience, Doug has cultivated a deep expertise in contract operations and managed care, positioning him as a key player in ensuring that Pfizer’s rebate strategies align with the dynamic needs of U.S. healthcare market access customers. Leading a dedicated team of seven professionals, Doug oversees the comprehensive administration of rebate agreements, ensuring accuracy and compliance while optimizing financial outcomes for both the company and its partners.
Doug’s leadership is characterized by a solution-oriented approach, leveraging advanced skills in reporting and analysis to drive data-informed decision-making. His proficiency in business intelligence (BI) tools and SQL enables him to extract actionable insights from complex datasets, enhancing the team's ability to manage contracts effectively and streamline payment processes. Furthermore, Doug’s adeptness in project management ensures that key initiatives are executed efficiently, fostering collaboration and communication across departments.
Currently, Doug is spearheading several high-impact projects aimed at refining rebate processes and enhancing operational efficiencies. By implementing innovative documentation practices and utilizing Microsoft Excel for detailed financial modeling, he is committed to delivering exceptional results that support Pfizer’s strategic objectives. Doug’s comprehensive understanding of the pharmaceutical industry, coupled with his strong analytical and communication skills, makes him an invaluable asset to the organization as it continues to navigate the evolving landscape of healthcare access and reimbursement.
